Page last updated: 2024-09-04

ethyl glucuronide and isoniazid

ethyl glucuronide has been researched along with isoniazid in 1 studies

Compound Research Comparison

Studies
(ethyl glucuronide)
Trials
(ethyl glucuronide)
Recent Studies (post-2010)
(ethyl glucuronide)
Studies
(isoniazid)
Trials
(isoniazid)
Recent Studies (post-2010) (isoniazid)
5142835021,8159604,493

Protein Interaction Comparison

ProteinTaxonomyethyl glucuronide (IC50)isoniazid (IC50)
MyeloperoxidaseHomo sapiens (human)4.85
Enoyl-[acyl-carrier-protein] reductase [NADH]Mycobacterium tuberculosis H37Rv8.29
Putative FAD-containing monooxygenase MymAMycobacterium tuberculosis H37Rv4.9

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Adong, J; Beesiga, B; Bryant, K; Chamie, G; Emenyonu, NI; Fatch, R; Gandhi, M; Hahn, JA; Havlir, DV; Kamya, MR; Kekibiina, A; Lodi, S; Marson, K; McDonell, MG; Muyindike, WR; Thirumurthy, H1

Trials

1 trial(s) available for ethyl glucuronide and isoniazid

ArticleYear
Financial incentives for reduced alcohol use and increased isoniazid adherence during tuberculosis preventive therapy among people with HIV in Uganda: an open-label, factorial randomised controlled trial.
    The Lancet. Global health, 2023, Volume: 11, Issue:12

    Topics: Adolescent; Adult; Alcoholism; Biomarkers; Ethanol; Female; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Motivation; Treatment Outcome; Tuberculosis; Uganda

2023